Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma

被引:0
|
作者
Hu, Wei [1 ,2 ,3 ]
Klumper, Niklas [1 ]
Schmidt, Doris [1 ]
Ritter, Manuel [1 ]
Ellinger, Jorg [1 ]
Hauser, Stefan [1 ,4 ]
机构
[1] Univ Hosp Bonn, Dept Urol, Bonn, Germany
[2] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Dept Urol, Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China
[4] Univ klinikum Bonn, Klinik & Poliklin Urol & Kinderurol, Bonn, Germany
来源
关键词
m6A-erasers; clear cell renal cell carcinoma (ccRCC); epithelial-mesenchymal transition (EMT); FTO; ALKBH5; DNA METHYLATION ANALYSIS; RNA; EXPRESSION; ERASERS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: N6-methyladenosine (m6A) is one of the most common RNA modifications in eukaryotes and has effects on RNA structure and stability. Recent studies have shown that m6A methylation is involved in human carcinogenesis. In the present study, we investigated the effects of m6A demethylases FTO and ALKBH5 on renal cell carcinoma (RCC) cell lines. Methods: The epithelial-mesenchymal in vitro knockdowns of FTO and ALKBH5 induced by antisense oligonucleotides (LNA-GapmeR system) were established in RCC cell lines. Their effects on migration and proliferation were investigated subsequently. The influence of FTO and ALKBH5 knockdown on key epithelialmesenchymal transition (EMT) genes was analyzed. Results: Inactivation of FTO and ALKBH5 resulted in decreased proliferation and motility in all cell lines examined (ACHN, Caki-1, 769-P). Vimentin (VIM) was downregulated after the knockdown of FTO and ALKBH5, indicating an EMT switch. Conclusions: Knockdown of the m6A erasers FTO and ALKBH5 inhibits the malignant potential in the cell cultures studied by means of an EMT switch.
引用
收藏
页码:1744 / +
页数:14
相关论文
共 50 条
  • [1] Insights into the m6A demethylases FTO and ALKBH5: structural, biological function, and inhibitor development
    Gao, Zewei
    Zha, Xuan
    Li, Min
    Xia, Xueli
    Wang, Shengjun
    CELL AND BIOSCIENCE, 2024, 14 (01):
  • [2] The m6A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35
    Yang, Zhiyuan
    Zhang, Siyu
    Xiong, Jiayan
    Xia, Tian
    Zhu, Rui
    Miao, Mengyu
    Li, Keying
    Chen, Wenyue
    Zhang, Lin
    You, Yiwen
    You, Bo
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [3] The m6A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35
    Zhiyuan Yang
    Siyu Zhang
    Jiayan Xiong
    Tian Xia
    Rui Zhu
    Mengyu Miao
    Keying Li
    Wenyue Chen
    Lin Zhang
    Yiwen You
    Bo You
    Cell Death Discovery, 10
  • [4] m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
    Xiao, Dong
    Fang, Ting-Xiao
    Lei, Ye
    Xiao, Sheng-Jun
    Xia, Jia-Wei
    Lin, Tao-Yan
    Li, Yong-Long
    Zhai, Jian-Xue
    Li, Xiao-Yan
    Huang, Shi-Hao
    Jia, Jun-Shuang
    Tian, Yu-Guang
    Lin, Xiao-Lin
    Cai, Kai-Can
    Sun, Yan
    AGING-US, 2021, 13 (17): : 21497 - 21512
  • [5] The N6-methyladenosine (m6A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma
    Strick, Alexander
    von Hagen, Felix
    Gundert, Larissa
    Kluemper, Niklas
    Tolkach, Yuri
    Schmidt, Doris
    Kristiansen, Glen
    Toma, Marieta
    Ritter, Manuel
    Ellinger, Joerg
    BJU INTERNATIONAL, 2020, 125 (04) : 617 - 624
  • [6] m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis
    Nagaki, Yushi
    Motoyama, Satoru
    Yamaguchi, Tomokazu
    Hoshizaki, Midori
    Sato, Yusuke
    Sato, Teruki
    Koizumi, Yukio
    Wakita, Akiyuki
    Kawakita, Yuta
    Imai, Kazuhiro
    Nanjo, Hiroshi
    Watanabe, Hiroyuki
    Imai, Yumiko
    Minamiya, Yoshihiro
    Kuba, Keiji
    GENES TO CELLS, 2020, 25 (08) : 547 - 561
  • [7] m6A demethylase ALKBH5 is associated with poor prognosis of esophageal squamous cell carcinoma patients.
    Nagaki, Yushi
    Kuba, Keiji
    CANCER SCIENCE, 2021, 112 : 432 - 432
  • [8] Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5
    Fang, Zhen
    Mu, Bo
    Liu, Yang
    Guo, Nihong
    Xiong, Liang
    Guo, Yinping
    Xia, Anjie
    Zhang, Rong
    Zhang, Hailin
    Yao, Rui
    Fan, Yan
    Li, Linli
    Yang, Shengyong
    Xiang, Rong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 238
  • [9] MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma
    Yang, Weifeng
    Xie, Lei
    Wang, Peng
    Zhuang, Changshui
    CELLULAR SIGNALLING, 2022, 91
  • [10] FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway
    Shen, Haixiang
    Ying, Yufan
    Ma, Xueyou
    Xie, Haiyun
    Chen, Shiming
    Sun, Jiazhu
    Liu, Zixiang
    Wen, Chao
    Yang, Zitong
    Wang, Xiao
    Xu, Mingjie
    Luo, Jindan
    Liu, Ben
    Li, Jiangfeng
    Zheng, Xiangyi
    Xie, Liping
    CELL DEATH DISCOVERY, 2022, 8 (01)